taspine has been researched along with Angiogenesis, Pathologic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, Y; Fan, M; Liu, R; Wang, B; Yu, R; Zhang, Y | 1 |
| Dai, B; Liu, R; Ma, Y; Wang, W; Zhang, Y | 1 |
| He, LC; Wang, HY; Zhang, YM | 1 |
3 other study(ies) available for taspine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Inhibitory effect of taspine derivative TAD1822-7 on tumor cell growth and angiogenesis via suppression of EphrinB2 and related signaling pathways.
Topics: A549 Cells; Alkaloids; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Ephrin-B2; Female; HEK293 Cells; Hep G2 Cells; Humans; Male; Neoplasms; Neovascularization, Pathologic; Rats, Sprague-Dawley; Signal Transduction | 2019 |
A taspine derivative supresses Caco-2 cell growth by competitively targeting EphrinB2 and regulating its pathway.
Topics: Alkaloids; Caco-2 Cells; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Ephrin-B2; HEK293 Cells; Humans; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor Receptor-2 | 2016 |
[Inhibitory effect of taspine on mouse S180 sarcoma and its mechanism].
Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; bcl-2-Associated X Protein; Berberidaceae; Cell Line, Tumor; Dose-Response Relationship, Drug; Fibroblast Growth Factor 2; Male; Mice; Neovascularization, Pathologic; Phytotherapy; Plant Roots; Plants, Medicinal; Proto-Oncogene Proteins c-bcl-2; Sarcoma 180; Vascular Endothelial Growth Factor A | 2007 |